All News Bluejay Diagnostics, Inc.

Equities

BJDX

US0956333019

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-14 pm EDT			5-day change	1st Jan Change
0.55 ^USD	+4.86%		+5.75%	-54.92%

Apr. 02	Bluejay Diagnostics, Inc. Appoints Neil Dey as Principal Financial and Accounting Officer	CI
Mar. 28	Bluejay Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bluejay Diagnostics, Inc. Appoints Neil Dey as Principal Financial and Accounting Officer	Apr. 02	CI
Bluejay Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering	Jan. 02	AQ
Top Premarket Decliners	Dec. 28	MT
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering	Dec. 28	AQ
Top Midday Decliners	Dec. 27	MT
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients	Dec. 27	CI
Bluejay Diagnostics Starts Clinical Study of Symphony IL-6 Test in Sepsis Patients; Shares Fall	Dec. 27	MT
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)	Dec. 27	AQ
Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results	Nov. 09	AQ
Bluejay Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Bluejay Diagnostics, Inc. Announces CFO Changes	23-10-02	CI
Bluejay Diagnostics, Inc. announced that it has received $1.59084 million in funding	23-08-27	CI
Sector Update: Health Care Stocks Climbing Late Afternoon	23-08-25	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	23-08-25	MT
Bluejay Diagnostics to Raise $1.6 Million in Registered Direct Offering	23-08-25	MT
Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules	23-08-25	AQ
Bluejay Diagnostics, Inc. announced that it expects to receive $1.59084 million in funding	23-08-23	CI
Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results	23-08-16	AQ
Bluejay Diagnostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Bluejay Diagnostics, Inc.

Equities

BJDX

US0956333019

All News

Filters